{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:21:00Z","timestamp":1780615260123,"version":"3.54.1"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000866","name":"IAVI","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000866","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>Adolescent girls and young women (AGYW) continue to face a significant risk of HIV infection, particularly as numerous experimental prevention products are in development. This study assessed the willingness to participate (WTP) in future clinical trials of long-acting HIV pre-exposure prophylaxis (PrEP) implants among AGYW at high risk of HIV infection in Kampala, Uganda. From January to October 2019, we conducted a cross-sectional study among AGYW aged 14\u201324 years. Interviewers _collected data on socio-demographics, substance use, sexual behavioural risk, contraceptive use and laboratory diagnosis of sexually transmitted infections (STIs). Participants were asked about their WTP in future clinical trials of a long-acting PrEP (LAP) implant. Multivariable logistic regression models were fitted to determine participant characteristics associated with WTP in future clinical trials of a PrEP implant. We enrolled 285 participants, with a median age of 20 years. Among them, 57.2% were single, 54.7% had completed at least secondary education, 92.6% engaged in transactional sex, 36.5% had multiple new male partners, 25.3% tested positive for STIs (chlamydia or gonorrhoea), and 15.4% reported drug use in the past three months. Nearly half (45.6%) of the AGYW expressed willingness to participate in a future HIV prevention study involving the LAP implant. Willingness to participate in a future HIV prevention study involving the LAP implant was higher among those with multiple new male partners (adjusted odds ratio [aOR] 1.84, 95%CI 1.09-3.11, <jats:italic><jats:italic>P<\/jats:italic><\/jats:italic>\u2009=\u20090.022) and those using contraceptives (aOR 1.69, 95% CI 1.00-2.85, <jats:italic><jats:italic>P<\/jats:italic><\/jats:italic>\u2009=\u20090.047) but lower among those with higher income levels (aOR 0.46, 95%CI 0.25-0.84, <jats:italic><jats:italic>P<\/jats:italic><\/jats:italic>\u2009=\u20090.013). These findings suggest that AGYW with higher HIV risk and those with prior contraceptive experience could potentially participate in future clinical trials of the LAP implant.<\/jats:p>","DOI":"10.1371\/journal.pgph.0005028","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T17:44:11Z","timestamp":1754675051000},"page":"e0005028","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Willingness of adolescent girls and young women to participate in future clinical trials of long-acting PrEP implants for HIV prevention, Kampala Uganda"],"prefix":"10.1371","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1261-2699","authenticated-orcid":true,"given":"Jane Frances","family":"Lunkuse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2624-4603","authenticated-orcid":true,"given":"Grace Godfrey","family":"Sseremba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Chetty-Makkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8386-7555","authenticated-orcid":true,"given":"Elizabeth","family":"Wahome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt A.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunia","family":"Mayanja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"pgph.0005028.ref001","unstructured":"UNAIDS. UNAIDS 2024 epidemiological estimates. 2024."},{"key":"pgph.0005028.ref002","unstructured":"UNAIDS. HIV and adolescent girls and young women\u20142024 Global AIDS Update. 2024. Available from: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2024-unaids-global-aids-update-adolescent-girls-young-women_en.pdf"},{"key":"pgph.0005028.ref003","unstructured":"CDC. Global HIV and TB. 2024. Available from: https:\/\/www.cdc.gov\/global-hiv-tb\/php\/success-stories\/dreams-saving-lives.html"},{"issue":"6","key":"pgph.0005028.ref004","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/inthealth\/ihab088","article-title":"Self-reported sexually transmitted infections among adolescent girls and young women in sub-Saharan Africa","volume":"14","author":"LK Dadzie","year":"2022","journal-title":"Int Health"},{"key":"pgph.0005028.ref005","doi-asserted-by":"crossref","first-page":"1198672","DOI":"10.3389\/frph.2023.1198672","article-title":"\u201cI fear those things\u201d: non-uptake of contraceptives, and barriers to use among adolescent girls and young women at high risk of HIV infection in Kampala, Uganda","volume":"5","author":"R Kawuma","year":"2023","journal-title":"Front Reprod Health"},{"issue":"1","key":"pgph.0005028.ref006","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1186\/s12889-023-17188-0","article-title":"Binge drinking and condom negotiation behaviours among adolescent girls and young women living in Cape Town, South Africa: sexual control and perceived personal power","volume":"23","author":"SE Singer","year":"2023","journal-title":"BMC Public Health"},{"issue":"9","key":"pgph.0005028.ref007","article-title":"Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya","volume":"16","author":"KK Mugwanya","year":"2019","journal-title":"PLoS ONE"},{"issue":"5","key":"pgph.0005028.ref008","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25909","article-title":"Oral pre-exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study","volume":"25","author":"Y Mayanja","year":"2022","journal-title":"J Int AIDS Soc"},{"issue":"9","key":"pgph.0005028.ref009","article-title":"Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study","volume":"19","author":"D Tapsoba J de","year":"2022","journal-title":"PLoS Med"},{"issue":"1","key":"pgph.0005028.ref010","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12905-022-02018-z","article-title":"Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers","volume":"22","author":"I Kayesu","year":"2022","journal-title":"BMC Womens Health"},{"issue":"4","key":"pgph.0005028.ref011","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s10508-020-01880-y","article-title":"Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South Africa","volume":"50","author":"R Muhumuza","year":"2021","journal-title":"Arch Sex Behav"},{"issue":"2","key":"pgph.0005028.ref012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246717","article-title":"Relationship dynamics and anticipated stigma: Key considerations for PrEP use among Tanzanian adolescent girls and young women and male partners","volume":"16","author":"N Jani","year":"2021","journal-title":"PLoS One"},{"issue":"9","key":"pgph.0005028.ref013","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1007\/s10461-022-03632-6","article-title":"Women\u2019s Perceptions of HIV- and Sexuality-Related Stigma in Relation to PrEP: Qualitative Findings from the Masibambane Study, Durban, South Africa","volume":"26","author":"S Bergam","year":"2022","journal-title":"AIDS Behav"},{"key":"pgph.0005028.ref014","unstructured":"WHO. WHO recommends long-acting cabotegravir for HIV prevention. 2021. Available from: https:\/\/www.who.int\/news\/item\/28-07-2022-who-recommends-long-acting-cabotegravir-for-hiv-prevention"},{"key":"pgph.0005028.ref015","unstructured":"WHO. WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection. 2021. Available from: https:\/\/www.who.int\/news\/item\/26-01-2021-who-recommends-the-dapivirine-vaginal-ring-as-a-new-choice-for-hiv-prevention-for-women-at-substantial-risk-of-hiv-infection"},{"key":"pgph.0005028.ref016","unstructured":"MOH. Consolidated guidelines for the prevention and treatment of HIV and AIDS in Uganda. 2022."},{"issue":"7","key":"pgph.0005028.ref017","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(20)30106-5","article-title":"Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial","volume":"7","author":"RJ Landovitz","year":"2020","journal-title":"Lancet HIV"},{"key":"pgph.0005028.ref018","unstructured":"Gilead\u2019s Twice-Yearly Lenacapavir Demonstrated 100% Efficacy and Superiority to Daily Truvada for HIV Prevention [press release]. 2024."},{"issue":"11","key":"pgph.0005028.ref019","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1093\/jac\/dkac252","article-title":"Safety and efficacy of a biodegradable implant releasing tenofovir alafenamide for vaginal protection in a macaque model","volume":"77","author":"I Massud","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"pgph.0005028.ref020","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jconrel.2020.12.024","article-title":"Design and Testing of a Cabotegravir Implant for HIV Prevention","volume":"330","author":"D Karunakaran","year":"2021","journal-title":"J Control Release"},{"issue":"9","key":"pgph.0005028.ref021","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1007\/s10461-022-03658-w","article-title":"HIV Pre-exposure Prophylaxis Implant Stated Preferences and Priorities: Results of a Discrete Choice Experiment Among Women and Adolescent Girls in Gauteng Province, South Africa","volume":"26","author":"KM Little","year":"2022","journal-title":"AIDS Behav"},{"issue":"4","key":"pgph.0005028.ref022","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/OLQ.0b013e3182099545","article-title":"HIV and other sexually transmitted infections in a cohort of women involved in high-risk sexual behavior in Kampala, Uganda","volume":"38","author":"J Vandepitte","year":"2011","journal-title":"Sex Transm Dis"},{"issue":"10","key":"pgph.0005028.ref023","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01058-18","article-title":"Extended-Duration MK-8591-Eluting Implant as a Candidate for HIV Treatment and Prevention","volume":"62","author":"SE Barrett","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"pgph.0005028.ref024","volume-title":"AUDIT: the Alcohol Use Disorders Identification Test: guidelines for use in primary health care\/ Thomas F. Babor \u2026 [et al.]","author":"WHO","year":"2001","edition":"2"},{"key":"pgph.0005028.ref025","unstructured":"UNCST. National guidelines for research involving humans as research participants. 2014. Available from: https:\/\/iuea.ac.ug\/sitepad-data\/uploads\/\/2021\/03\/Human-Subjects-Protection-Guidelines-July-2014.pdf"},{"key":"pgph.0005028.ref026","unstructured":"Nanvubya A, Mpendo J, Ssetaala A, Kidega W, Sigirenda S, Nielsen L, et al. Willingness to participate in HIV vaccine efficacy trials in a population of fishing communities, Uganda. (1742-4690 (Electronic))."},{"issue":"8","key":"pgph.0005028.ref027","article-title":"Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya","volume":"15","author":"EM Mutisya","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pgph.0005028.ref028","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1186\/s12889-020-09932-7","article-title":"Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study","volume":"20","author":"Y Mayanja","year":"2020","journal-title":"BMC Public Health"},{"issue":"44","key":"pgph.0005028.ref029","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1016\/j.vaccine.2013.08.080","article-title":"Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda","volume":"31","author":"G Asiki","year":"2013","journal-title":"Vaccine"},{"issue":"11","key":"pgph.0005028.ref030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206656","article-title":"Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults-Experience from Kenya","volume":"13","author":"DK Nyasani","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"pgph.0005028.ref031","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12910-020-00516-z","article-title":"\u201cYou would not be in a hurry to go back home\u201d: patients\u2019 willingness to participate in HIV\/AIDS clinical trials at a clinical and research facility in Kampala, Uganda","volume":"21","author":"DE Sebatta","year":"2020","journal-title":"BMC Med Ethics"},{"issue":"5","key":"pgph.0005028.ref032","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1521\/aeap.2020.32.5.392","article-title":"Associations Among HIV Risk Perception, Sexual Health Efficacy, and Intent to Use PrEP Among Women: An Application of the Risk Perception Attitude Framework","volume":"32","author":"WC Sewell","year":"2020","journal-title":"AIDS Educ Prev"},{"issue":"9","key":"pgph.0005028.ref033","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1007\/s10461-023-04008-0","article-title":"HIV Risk Perception, Willingness to Use PrEP, and PrEP Uptake Among Young Men who have Sex with Men in Washington, DC","volume":"27","author":"H Yellin","year":"2023","journal-title":"AIDS Behav"},{"key":"pgph.0005028.ref034","unstructured":"Kff. Contraceptive Implants. 2019. Available from: https:\/\/www.kff.org\/womens-health-policy\/fact-sheet\/contraceptive-implants\/"},{"issue":"8","key":"pgph.0005028.ref035","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/cncr.32730","article-title":"Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology","volume":"126","author":"MS von Itzstein","year":"2020","journal-title":"Cancer"},{"key":"pgph.0005028.ref036","doi-asserted-by":"crossref","first-page":"1369256","DOI":"10.3389\/fpubh.2024.1369256","article-title":"Preference for novel biomedical HIV pre-exposure prophylaxis methods among adolescent girls and young women in Kampala, Uganda: a mixed methods study","volume":"12","author":"Y Mayanja","year":"2024","journal-title":"Front Public Health"},{"issue":"10","key":"pgph.0005028.ref037","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(22)00195-3","article-title":"Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial","volume":"9","author":"J Velloza","year":"2022","journal-title":"Lancet HIV"},{"issue":"5","key":"pgph.0005028.ref038","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25909","article-title":"Oral pre-exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study","volume":"25","author":"Y Mayanja","year":"2022","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"pgph.0005028.ref039","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/QAI.0000000000001762","article-title":"HIV Pre-Exposure Prophylaxis Stigma as a Multidimensional Barrier to Uptake Among Women Who Attend Planned Parenthood","volume":"79","author":"SK Calabrese","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"pgph.0005028.ref040","article-title":"Low condom use at the last sexual intercourse among university students in sub-Saharan Africa: evidence from a systematic review and meta-analysis","volume":"17","author":"J Izudi","year":"2022","journal-title":"BMC Public Health"},{"issue":"1","key":"pgph.0005028.ref041","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1043659604270962","article-title":"Culture and context of HIV prevention in rural Zimbabwe: the influence of gender inequality","volume":"16","author":"L Duffy","year":"2005","journal-title":"J Transcult Nurs"},{"issue":"4","key":"pgph.0005028.ref042","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1080\/17441692.2020.1869286","article-title":"Exploring factors associated with HIV secondary stigma among adolescents and young adults in Uganda: A cross-sectional study","volume":"17","author":"E Small","year":"2022","journal-title":"Glob Public Health"},{"issue":"3","key":"pgph.0005028.ref043","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1089\/apc.2019.0242","article-title":"Contraception as a Potential Gateway to Pre-Exposure Prophylaxis: US Women\u2019s Pre-Exposure Prophylaxis Modality Preferences Align with Their Birth Control Practices","volume":"34","author":"SK Calabrese","year":"2020","journal-title":"AIDS Patient Care STDS"},{"issue":"13","key":"pgph.0005028.ref044","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1177\/0956462420951501","article-title":"Alignment of PrEP use and effective contraceptive use among East African women in HIV serodiscordant partnerships","volume":"31","author":"K Ngure","year":"2020","journal-title":"Int J STD AIDS"},{"issue":"3","key":"pgph.0005028.ref045","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s10461-023-04202-0","article-title":"Preferences for Long-Acting PrEP Products Among Women and Girls: A Quantitative Survey and Discrete Choice Experiment in Eswatini, Kenya, and South Africa","volume":"28","author":"KM Little","year":"2024","journal-title":"AIDS Behav"},{"issue":"6","key":"pgph.0005028.ref046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001191","article-title":"Factors associated with willingness to take Pre-Exposure Prophylaxis (PrEP) among high-risk adolescent boys and young men in Masese fishing community, Uganda","volume":"3","author":"W Agwang","year":"2023","journal-title":"PLOS Glob Public Health"},{"issue":"2","key":"pgph.0005028.ref047","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/JNC.0000000000000384","article-title":"What Factors Are Associated With Willingness to Use HIV Pre-exposure Prophylaxis (PrEP) Among U.S. Men Who Have Sex With Men Not on PrEP? A Systematic Review and Meta-analysis","volume":"34","author":"E Kamitani","year":"2023","journal-title":"J Assoc Nurses AIDS Care"},{"issue":"3","key":"pgph.0005028.ref048","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/apc.2012.0412","article-title":"Attitudes toward HIV pre-exposure prophylaxis among men who have sex with men in western China","volume":"27","author":"Y Zhang","year":"2013","journal-title":"AIDS Patient Care STDS"},{"issue":"1","key":"pgph.0005028.ref049","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/QAI.0b013e31818d5a27","article-title":"Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education","volume":"50","author":"MJ Mimiaga","year":"2009","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0005028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T17:44:21Z","timestamp":1754675061000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0005028"}},"subtitle":[],"editor":[{"given":"Tsitsi B.","family":"Masvawure","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0005028","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]}}}